39U-97033-89716
2 vaccinations
0 coded responses
13 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 064 / CT
- Registered
- 2022-03-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-21
Dose 1 — Janssen/Johnson & Johnson
-
2022-03-23
Dose 2 — Moderna
-
2022-03-24
Registered in v-safe
-
2022-03-24
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-03-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-03-26
- 2022-03-27
- 2022-03-28
- 2022-03-29
- 2022-04-01
- 2022-04-13
- 2022-04-20
- 2022-04-27
- 2022-05-04
- 2022-06-29
- 2022-09-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-21 | Janssen/Johnson & Johnson | No |
| 2 | 2022-03-23 | Moderna | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.